Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Baillière's Best Practice & Research: Clinical Haematology

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.beha.2016.11.002PMID 28288706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion‐weighted imaging and dynamic contrast‐enhanced MRI

  2017cited by this paper
• A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.

  2017cited by this paper
• Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T

  2017cited by this paper
• Delayed Efficacy After Treatment With Lenalidomide or Thalidomide in Patients With Mucosa-Associated Lymphoid Tissue Lymphoma.

  2016cited by this paper
• Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

  2016cited by this paper
• Comprehensive Genomic Profiling of Orbital and Ocular Adnexal Lymphomas Identifies Frequent Alterations in MYD88 and Chromatin Modifiers: New Routes to Targeted Therapies

  2016cited by this paper
• Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma

  2015cited by this paper
• Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.

  2015cited by this paper
• High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.

  2015cited by this paper
• Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience

  2015cited by this paper
• Phase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma

  2015cited by this paper
• Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.

  2014cited by this paper
• Efficacy of 90Yttrium‐ibritumomab tiuxetan in relapsed/refractory extranodal marginal‐zone lymphoma

  2014cited by this paper
• Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma

  2014cited by this paper
• First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.

  2014cited by this paper
• Clinical activity of everolimus in relapsed/refractory marginal zone B‐cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

  2014cited by this paper
• 90Y‐ibritumomab tiuxetan radiotherapy as first‐line therapy for early stage low‐grade B‐cell lymphomas, including bulky disease

  2014cited by this paper
• Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentöse Tumortherapie

  2013cited by this paper
• Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study.

  2013cited by this paper
• A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)

  2013cited by this paper
• Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections

  2013cited by this paper
• Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

  2012cited by this paper
• Risk of radiation retinopathy in patients with orbital and ocular lymphoma.

  2012cited by this paper
• Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae

  2012cited by this paper
• Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation

  2012cited by this paper
• Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.

  2011cited by this paper
• Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation.

  2011cited by this paper
• Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG).

  2011cited by this paper
• Primary, Unilateral Ocular Adnexal Lymphoma: Disease Progression and Long-Term Survival

  2011cited by this paper
• Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin’s lymphoma

  2011cited by this paper
• Genomic profiles of MALT lymphomas: variability across anatomical sites

  2011cited by this paper
• Six‐month oral clarithromycin regimen is safe and active in extranodal marginal zone B‐cell lymphomas: final results of a single‐centre phase II trial

  2010cited by this paper
• Ocular adnexal lymphoma: diffusion-weighted mr imaging for differential diagnosis and therapeutic monitoring.

  2010cited by this paper
• Radiation Cataractogenesis: A Review of Recent Studies

  2009cited by this paper
• Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).

  2009cited by this paper
• Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.

  2009cited by this paper
• Chlamydial infection: the link with ocular adnexal lymphomas

  2009cited by this paper
• A phase II study of bortezomib in patients with MALT lymphoma

  2009cited by this paper
• Combination therapy with rituximab and intravenous or oral fludarabine in the first‐line, systemic treatment of patients with extranodal marginal zone B‐cell lymphoma of the mucosa‐associated lymphoid tissue type

  2009cited by this paper
• Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy.

  2008cited by this paper
• Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients

  2008cited by this paper
• The association between conjunctival MALT lymphoma and Helicobacter pylori

  2008cited by this paper
• Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study

  2008cited by this paper
• BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

  2008cited by this paper
• Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

  2008cited by this paper
• Ocular adnexal lymphoma. What is the evidence for an infectious aetiology?

  2008cited by this paper
• Chlamydia Infection and Lymphomas: Association Beyond Ocular Adnexal Lymphomas Highlighted by Multiple Detection Methods

  2008cited by this paper
• MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course

  2007cited by this paper
• Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma

  2007cited by this paper
• Activity of Rituximab plus Cyclophosphamide, Doxorubicin/Mitoxantrone, Vincristine and Prednisone in Patients with Relapsed MALT Lymphoma

  2007cited by this paper
• Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma.

  2007cited by this paper
• Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma-is there an association? The German experience.

  2007cited by this paper
• Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma

  2006cited by this paper
• Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphoma

  2006cited by this paper
• Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa.

  2006cited by this paper
• Diffusion-weighted magnetic resonance imaging and its application to cancer

  2006cited by this paper
• Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.

  2006cited by this paper
• Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT.

  2006cited by this paper
• Screening options for diabetic retinopathy.

  2006cited by this paper
• Radiotherapy and Cataract Formation

  2006cited by this paper
• Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience.

  2006cited by this paper
• Lymphomas involving the eye and the ocular adnexa

  2006cited by this paper
• Rapidly increasing incidence of ocular non-hodgkin lymphoma.

  2006cited by this paper
• Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.

  2006cited by this paper
• Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma.

  2006cited by this paper
• Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.

  2006cited by this paper
• Hepatitis C virus infection and MALT-type ocular adnexal lymphoma.

  2006cited by this paper
• Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions

  2006cited by this paper
• Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.

  2006cited by this paper
• Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.

  2005cited by this paper
• Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production.

  2005cited by this paper
• Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy.

  2005cited by this paper
• Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public

  2005cited by this paper
• Delving deeper into MALT lymphoma biology.

  2005cited by this paper
• Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study.

  2005cited by this paper
• No evidence of a correlation between BCL10 expression and API2‐MALT1 gene rearrangement in ocular adnexal MALT lymphoma

  2004cited by this paper
• Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites

  2004cited by this paper
• Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

  2004cited by this paper
• Chlamydia and apoptosis: life and death decisions of an intracellular pathogen

  2004cited by this paper
• MALT lymphoma: from morphology to molecules

  2004cited by this paper
• Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma.

  2004cited by this paper
• Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).

  2003cited by this paper
• Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.

  2003cited by this paper
• Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.

  2003cited by this paper
• Clinicopathologic analysis of ocular adnexal lymphomas: Extranodal marginal zone b‐cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients

  2003cited by this paper
• T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.

  2003cited by this paper
• Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.

  2003cited by this paper
• Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.

  2003cited by this paper
• Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

  2003cited by this paper
• Orbital lymphoma: is it necessary to treat the entire orbit?

  2003cited by this paper
• Animal-related occupations and the risk of leukemia, myeloma, and non-Hodgkin's lymphoma in Canada

  2002cited by this paper
• Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.

  2002cited by this paper
• Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma.

  2001cited by this paper
• Orbital lymphoma: radiotherapy outcome and complications.

  2001cited by this paper
• The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages.

  2001cited by this paper
• Clinical, Histopathological, and Immunogenetic Analysis of Ocular Adnexal Lymphoproliferative Disorders: Characterization of MALT Lymphoma and Reactive Lymphoid Hyperplasia

  2001cited by this paper
• Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma

  2000cited by this paper
• Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival

  2000cited by this paper
• Adjuvant Effect of Clarithromycin on Chemotherapy for Murine Lung Cancer

  1999cited by this paper
• Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

  1999cited by this paper

• Burkitt's lymphoma presenting as acute dacryocystitis in a 14-year-Old male with ataxia telangiectasia: A case report and review of the literature

  2025cites this paper
• Association of Chlamydia species with ocular adnexal mucosa-associated lymphoid tissue lymphoma in Taiwan

  2025cites this paper
• The prevalence and characteristics of ocular adnexal lymphomas of the conjunctiva and orbit

  2025cites this paper
• Ocular Adnexal Marginal Zone Lymphoma: Retrospective Analysis and Clinical-Pathological Features

  2025cites this paper
• Non-gastric mucosa-associated lymphoid tissue lymphomas: a narrative review of pathogenesis, diagnosis, and treatment strategies

  2025cites this paper
• Subepithelial Lesions of the Ocular Surface: A Review

  2025cites this paper
• Salvage Irradiation for Ocular Adnexal Mucosa Associated Lymphoid Tissue Lymphoma Refractory to Chlamydia psittaci Eradication

  2025cites this paper
• Space radiation and risk for ocular surface malignancies: Exposure risk, current mitigation strategies, and management considerations for a mission to Mars.

  2025cites this paper
• Single-cell RNA-sequencing reveals cellular heterogeneity and immune microenvironment characteristics between ocular adnexal mucosa-associated lymphoid lymphoma and IgG4−related ophthalmic disease

  2025cites this paper
• Chlamydia psittaci Screening of Animal Workers from Argentina Exposed to Carrier Birds

  2024cites this paper
• [Viral and chlamydial conjunctivitis].

  2024cites this paper
• The Dilemma for Early-Stage Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma: To Treat or Not to Treat?

  2024cites this paper
• Infectious etiologies of conjunctival tumors

  2024cites this paper
• Construction and validation of a novel web-based nomogram for primary ocular adnexal lymphoma: a real-world analysis based on the Surveillance, Epidemiology, and End Results database

  2024cites this paper
• Clinical analysis of 94 cases of ocular adnexal lymphomas

  2024cites this paper
• Lymphoma Involvement of the Eyelid and Eye.

  2024cites this paper
• The possible role of Helicobacter pylori in liver diseases

  2023cites this paper
• Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals.

  2023cites this paper
• Predicting the prognosis of primary orbital lymphoma by clinical characteristics and imaging features.

  2023cites this paper
• Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives

  2022cites this paper
• Moderne pathologische Diagnostik und systemische Therapie

  2022cites this paper
• Long‐term outcomes of patients with conjunctival extranodal marginal zone lymphoma

  2022cites this paper
• Lymphome des Auges und seiner Adnexe

  2022cites this paper
• The Biology of Ocular Adnexal Marginal Zone Lymphomas

  2022cites this paper
• One Case of Conjunctival MALT Lymphoma and Literature Review

  2022cites this paper
• 18F-FDG PET/CT Findings of MALT Lymphoma of Ureter.

  2022cites this paper
• Current Treatment of Conjunctival Malignancies

  2021cites this paper
• Tear cytokine profiles in patients with extranodal marginal zone B-cell lymphoma of the ocular adnexa

  2021cites this paper
• Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment

  2021cites this paper
• Pathology of the Orbit: Neoplasms

  2021cites this paper
• Candida parapsilosis osteomyelitis following dog bite: a case report and review of the literature.

  2021cites this paper
• Pathology of the Conjunctiva

  2020cites this paper
• The B cell receptor in marginal zone lymphoma ontogeny and evolution

  2020influential citation
• Orbital and Eyelid B-Cell Lymphoma: A Multicenter Retrospective Study

  2020cites this paper
• Gene fusions in ocular adnexal tumors.

  2020cites this paper
• Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017

  2020cites this paper
• Involvement of Helicobacter Pylori in Ocular Adnexa Lymphoma

  2020cites this paper
• Visual Acuity Loss in a Healthy Man.

  2020cites this paper
• Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.

  2020cites this paper
• Hepatitis C virus in MALT-lymphoma of the ocular adnexa.

  2020cites this paper
• Case Report: Primary Conjunctival Non-Hodgkin Marginal Zone Lymphoma.

  2019cites this paper
• Orbital Lymphoma-An International Multicenter Retrospective Study.

  2019cites this paper
• Ocular adnexal marginal zone lymphoma (OAMZL)

  2019cites this paper
• Prevalence of Chlamydia psittaci, Chlamydia pneumoniae, and Chlamydia trachomatis Determined by Molecular Testing in Ocular Adnexa Lymphoma Specimens.

  2019cites this paper
• Classification, diagnosis, and management of conjunctival lymphoma

  2019cites this paper
• Patterns of care for orbital marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue in Korea throughout 2016: Results from a multicenter cross‐sectional cohort study (KROG 16–19)

  2019cites this paper
• Marginal zone lymphomas: second most common lymphomas in older patients.

  2019cites this paper
• International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma

  2019cites this paper
• Pharmacotherapy for Conjunctival Malignancies

  2019cites this paper
• Lacrimal Gland Tumors

  2018cites this paper
• Recent advances in treating extra-ocular lymphomas

  2018cites this paper
• Survival in B-cell primary ocular lymphoma 1997–2014: a population-based study

  2018cites this paper
• Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study

  2018cites this paper
• Maligne Lymphome des Auges

  2017cites this paper
• Overview on the management of non-gastric MALT lymphomas.

  2017cites this paper